J. van der Sar

Phase I Evaluation of Telatinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Irinotecan and Capecitabine in Patients with Advanced Solid Tumors

J. Schellens, E. Voest, H. Verheul, 2010, Clinical Cancer Research.

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors.

J. Schellens, David M. Wilson, E. Voest, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I Evaluation of Telatinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Irinotecan and Capecitabine in Patients with Advanced Solid Tumors

J. Schellens, E. Voest, H. Verheul, 2010, Clinical Cancer Research.